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ABSTRACT Modular bacteriocins represent a major group of secreted protein toxins
with a narrow spectrum of activity, involved in interference competition between
Gram-negative bacteria. These antibacterial proteins include a domain for binding to
the target cell and a toxin module at the carboxy terminus. Self-inhibition of pro-
ducers is provided by coexpression of linked immunity genes that transiently inhibit
the toxin’s activity through formation of bacteriocin-immunity complexes or by in-
sertion in the inner membrane, depending on the type of toxin module. We demon-
strate strain-speciﬁc inhibitory activity for PmnH, a Pseudomonas bacteriocin with an
unprecedented dual-toxin architecture, hosting both a colicin M domain, potentially
interfering with peptidoglycan synthesis, and a novel colicin N-type domain, a pore-
forming module distinct from the colicin Ia-type domain in Pseudomonas aerugi-
nosa pyocin S5. A downstream-linked gene product confers PmnH immunity
upon susceptible strains. This protein, ImnH, has a transmembrane topology sim-
ilar to that of Pseudomonas colicin M-like and pore-forming immunity proteins,
although homology with either of these is essentially absent. The enhanced kill-
ing activity of PmnH under iron-limited growth conditions reﬂects parasitism of
the ferrichrome-type transporter for entry into target cells, a strategy shown
here to be used as well by monodomain colicin M-like bacteriocins from pseu-
domonads. The integration of a second type of toxin module in a bacteriocin
gene could offer a competitive advantage against bacteria displaying immunity
against only one of both toxic activities.
IMPORTANCE In their continuous struggle for ecological space, bacteria face a
huge load of contenders, including phylogenetically related strains that compete
for the same niche. One important group of secreted antibacterial proteins as-
sisting in eliminating these rivals are modular bacteriocins of Gram-negative bac-
teria, comprising a domain for docking onto the cell envelope of a target cell, a
translocation domain enabling subsequent cellular entry, and a toxin module
that kills target cells via enzymatic or pore-forming activity. We here demon-
strate the antagonistic function of a Pseudomonas bacteriocin with unique archi-
tecture that combines a putative enzymatic colicin M-like domain and a novel
pore-forming toxin module. For target cell recognition and entry, this bacteriocin
hybrid takes advantage of the ferrichrome transporter, also parasitized by enzy-
matic Pseudomonas bacteriocins devoid of the pore-forming module. Bacteriocins
with an expanded toxin potential may represent an inventive bacterial strategy
to alleviate immunity in target cells.
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The metabolically versatile genus Pseudomonas is able to colonize very diversecompetitive niches and includes a tremendous variety of organisms ranging from
opportunistic pathogens to plant growth-promoting bacteria and environmental pol-
lutant degraders (1, 2). To face competitors, pseudomonads are armed with an arsenal
of antagonistic molecules, diverse both from a structural point of view and in mecha-
nism of action. A subset of these Pseudomonas compounds are bacteriocins, secreted
ribosomally synthesized antibacterial peptides and proteins that selectively kill related
bacteria (3). In Pseudomonas aeruginosa in particular, bacteriocins—there called pyo-
cins—have been associated with an ecoevolutionary advantage for producer strains
(4–7).
Several classes of Pseudomonas bacteriocins have been identiﬁed. Together with the
multisubunit cell-perforating tailocins (8), S-type bacteriocins constitute a very abun-
dant group in Pseudomonas genomes (3). These modular polypeptides resemble the
colicins from Escherichia coli (9) and share a general organization that includes a
domain for target cell attachment, a domain mediating subsequent translocation, and
a carboxy-terminal toxin domain. The latter may display nuclease activity, as, for
example, found in pyocins S1 (DNase), S4 (tRNase), and S6 (rRNase), or possess
pore-forming function, as in pyocin S5 (PyoS5) (3, 10). Less widespread in pseudomon-
ads are M-type bacteriocins (PseuMs), equipped with a colicin M (ColM) domain and
exerting enzymatic activity in the periplasm, via cleavage of the lipid II peptidoglycan
precursor (11–13).
Self-inhibition of strains producing modular pyocins is prevented by coexpression of
an immunity gene, located downstream of the bacteriocin gene on the same or
opposite strand. These immunity proteins shield the toxin part of the bacteriocins by
formation of toxin-immunity complexes, as structurally elucidated for the nucleases of
pyocins S2 and AP41 (14). Lethality due to pore formation by pyocin S5 (PyoS5) is
transiently impeded along the secretory route via a membrane-integrated protein
consisting of three transmembrane helices (TMHs) (15). PseuM immunity is also deliv-
ered by a membrane-integrated protein, called PmiA, consisting of four TMHs but
showing no sequence similarity to the PyoS5 immunity protein (16). In contrast to other
immunity proteins protecting from enzymatic toxin domains, PmiA proteins display
very poor sequence homology with the exception of a short semiconserved periplasmic
motif, whose role in the PseuM immunity mechanism remains elusive at this point.
The target for bacteriocin docking onto cells has been identiﬁed for several S
pyocins. It typically concerns outer membrane proteins (OMPs) involved in the uptake
of iron via siderophores: type I ferripyoverdine transporter FpvAI for pyocins S2, S4, and
SD2 (17–19), type II ferripyoverdine transporter FpvAII for pyocin S3 (20), and ferripyo-
chelin receptor FptA for pyocin S5 (21). Some S pyocins carry (almost) identical
amino-terminal regions and basically differ only in their toxin-immunity module, em-
phasizing the peculiar modularity of these allelopathic molecules. Although omnipres-
ent in Pseudomonas genomes (3), few S-type bacteriocins have been functionally
characterized in other Pseudomonas species (22). To date, their partner mediating initial
binding and also the one(s) of PseuMs remain unknown. Since signiﬁcant structural
similarity was observed between the PseuMs from P. aeruginosa and Pseudomonas
syringae and colicin M from E. coli, it was suggested that these bacteriocins share a
common ancestry and may target the same type of cell surface component (12, 13, 23).
In this study, we demonstrate the antagonistic functionality of a unique Pseudomo-
nas bacteriocin that hosts two toxin modules. This bacteriocin carries a ColM domain
and is followed by a novel type of pore-forming domain, not previously described in
Pseudomonas. The role of a gene located downstream of the bacteriocin in providing
immunity is also explored. We further show that this bacteriocin targets a TonB-
dependent OMP that shares homology with the ferrichrome transporter from P. aerugi-
nosa. We also demonstrate that two different PseuM bacteriocins equally target this
surface-exposed protein.
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RESULTS
PmnH combines an enzymatic domain and a novel type of pore-forming
module. Known modular bacteriocins host a single toxin domain and are accompanied
by a cognate immunity protein to prevent self-inhibition. However, genome analysis in
pseudomonads has revealed genes encoding putative bacteriocins with two nuclease
modules at their C termini: the “hybrids” PsdH1 and PsdH2 are typiﬁed by two S1-like
DNase domains and by an S1-like and S3-like DNase domain, respectively (3). Yet
another hybrid organization, comprising two apparently unrelated modules, is found in
PmnH, joining a ColM domain (Pfam PF14859) to a pore-forming domain (Pfam
PF01024) (Fig. 1A) (24). This pore-forming domain is phylogenetically distinct from the
domain in pyocin S5 (PyoS5) (Fig. 1B; see also Fig. S1 in the supplemental material): the
latter domain is more closely related to colicin Ia (ColIa) (25), whereas PmnH’s
C-terminal domain belongs to a clade with colicin N (ColN) (26, 27), sharing 44.6% and
33.5% amino acid identity to the corresponding colicin domains, respectively. The
ColIa-type pore-forming domain of pyocin S5 is present in ~28% of the sequenced
P. aeruginosa genomes (draft and full genomes), whereas the ColN-type pore-forming
FIG 1 (A) Schematic gene organizations of representative ColM- and pore domain-containing bacteriocin genes and (putative) immunity genes in
pseudomonads. Arrows correspond with gene orientations. The color key outlines the different bacteriocin domains and immunity gene type. (B and C)
Maximum likelihood phylogenetic trees of pore-forming domains (B) and ColM domains (C) from (hypothetical) Pseudomonas bacteriocins and characterized
betaproteobacterial/gammaproteobacterial bacteriocins. Highly homologous domains (95% pairwise amino acid identity) are not included. The scale bars
represent 0.5 (B) and 0.7 (C) substitutions per site. Bootstrap values (percentages of 1,000 replicates) higher than 50 are shown at the branches. PmnH from
Pseudomonas synxantha BG33R was selected as a PmnH representative, and its corresponding pore-forming and ColM domains are colored blue; colicin Ia
(ColIa), colicin N (ColN), and colicin M (ColM) domains from E. coli are shown in green, teal, and red, respectively; ColM domains from Pectobacterium and
Burkholderia are shown in pink and orange, respectively. (B) P. putida PA14H7 encodes two different pore-forming bacteriocins, one equipped with a ColN-type
domain (1) and one with a ColIa-type domain (2). (C) Pseudomonas PseuM bacteriocins followed by a (predicted) pmiA-type immunity gene are grouped by
an arc. Abbreviations for species names: Bamb, Burkholderia ambifaria; Ecoli, Escherichia coli; Paer, Pseudomonas aeruginosa; Pbra, Pseudomonas brassicacearum;
Pcar, Pectobacterium carotovorum; Pchl, Pseudomonas chlororaphis; Pcor ory, Pseudomonas coronafaciens pv. oryzae; Pﬂu, Pseudomonas ﬂuorescens; Plib,
Pseudomonas libanensis; Pput, Pseudomonas putida; Psp, Pseudomonas sp.; Psyn, Pseudomonas synxantha; Psyr (tom), Pseudomonas syringae (pv. tomato); Pthi,
Pseudomonas thivervalensis; Ptol, Pseudomonas tolaasii.
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domain can be retrieved only in other Pseudomonas species. Overall, (putative) pore-
forming bacteriocins, of either the ColIa or the ColN type, are very rare in Pseudomonas
species other than P. aeruginosa, and they are encoded in only a few strains (24 isolates
versus 800 draft and full genomes). The opposite was previously observed for rRNase
bacteriocins that are rare in P. aeruginosa but very abundant in other Pseudomonas
species (3).
The ColM domain of PmnH contains several of the coordinating residues previously
associated with structural integrity and catalytic activity in colicin M from E. coli and
PseuMs from P. aeruginosa and P. syringae (Fig. S2) (12, 13, 28). The equivalent of the
E. coli pivotal motif DxYD(x5)HR in the carboxy-terminal part of the ColM module
(residues 226 to 236) is present in nearly all PmnH proteins as HxYD(x5)FK (positions 224
to 234, with x representing any amino acid). The His224 and Lys234 residues, deviating
from the prototypical ColM motif, are not present in any other pseudomonad ColM
domain, in contrast to the frequently present Phe233 (such as in PseuMs from Pseu-
domonas sp. strain GM21 and Pseudomonas tolaasii 6264). Among the PmnH-encoding
strains, the equivalent sequence in Pseudomonas sp. strain 25R14 [IxYT(x5)LK] (29)
deviates substantially from the ColM-derived consensus motif. A diverged ColM motif
not affecting bactericidal activity was previously observed for M-type burkhocins, for
example as DxYK(x5)-R in BurM1 of Burkholderia ambifaria MEX-5 (30). In this case,
possible lipid II hydrolase activity was not examined. The amino acid sequence of the
ColM domain of PmnH clusters with those of the equivalent domains of PseuMs, being
protected by PmiA immunity proteins (Fig. 1C) (16).
The pmnH gene (1,389 bp) occurs in isolates from several Pseudomonas species,
originating from diverse sources such as rhizosphere, water, and cystic ﬁbrosis lung:
Pseudomonas ﬂuorescens (AU14440, LBUM223, KENGFT3, and Ps_40), Pseudomonas
libanensis (BS2975, DSM 17149, and RIT-PI-g), Pseudomonas synxantha (BG33R), and
other Pseudomonas sp. strains (25R14, BRG-100, Root9, and Root569). The encoded
PmnH sequences show near-perfect conservation (~98% pairwise amino acid identity),
with the notable exception of the more diverged 25R14 protein (~59% amino acid
identity). The highly conserved pmnH genes are part of a stretch of ~2.5 kb with
lower-than-average GC content (~48% versus ~61%) and reside in a semivariable
context with strain-dependent differences, suggesting that the pmnH-ﬂanking se-
quences have been subject to various rearrangements (Fig. 2). The region upstream of
pmnH encodes a putative tripartite efﬂux pump of the major facilitator family (opposite
strand) and a putative two-partner secretion (TPS) system for a hemagglutinin repeat
protein (same strand). In a number of strains, a second type of TPS system is present
further downstream of pmnH (opposite strand), sometimes joined by a shorter, partially
homologous hemagglutinin repeat gene (possibly a fragmented gene remnant). The
presence of Pfam domain DUF637 with a conserved NEALL motif in the proteins
encoded by the downstream hemagglutinin repeat genes (detected in strains AU14440,
Root9, and Ps_40) suggests that these TPS systems may be part of a contact-dependent
inhibition (CDI) cassette (31). In addition to bacteriocins, CDI systems play key roles in
interbacterial competition, although conﬁned to inhibition of neighboring cells (32). In
closer proximity to pmnH, a number of genes without known function arise, as well as
more unique interspersed genes (Fig. 2). The more divergent pmnH homologue from
Pseudomonas sp. 25R14 has been recruited to a different but also poorly conserved
region, equally harboring a TPS system but distinct from those found in the other
pmnH-carrying strains. Notably, some of the pmnH-carrying strains also encode a
“regular” single-toxin form of bacteriocin with the same, ColN-type pore-forming domain
(Pseudomonas sp. strain BRG-100) or of the ColIa/PyoS5 type (P. libanensis RIT-PI-g). Both
types of monofunctional bacteriocin genes are found in the pmnH-lacking Pseudomonas
putida PA14H7, as cargo of its tailocin (8).
PmnH antagonistic activity requires the pore-forming domain. Among the highly
conserved pmnH genes, the one from P. synxantha BG33R (encoding PSEBG33_RS05990)
was selected for further characterization. Previously, it was found that a short proline-
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rich sequence at the amino terminus of the PseuM from a P. syringae pathovar is
required for cytotoxicity (13), and a similar semiconserved sequence was detected in
ColM-like bacteriocins from other Pseudomonas species (16) and Burkholderia (30). Such
a sequence may act as a functional equivalent of the TonB box from colicin M in E. coli
and is equally present in the gene product of pmnH (Fig. S3). To avoid interference of
the His tag with the possible import-related function of this sequence, pmnH was
cloned to encode a C-terminal tag. After recombinant expression and puriﬁcation,
antagonistic activity of His-tagged PmnH was evaluated against a panel of Pseudomo-
nas strains (type strains and a selection of in-house environmental isolates, n  35), of
which ~11% proved susceptible (Table S1). Susceptibility of the indicator strains
markedly increased when bacteria were grown in and plated on iron-poor media such
as King’s B and Casamino Acids medium (CAA) (Fig. 3A). On the other hand, when the
FIG 2 Genetic organization of the pmnH loci in Pseudomonas spp. Synteny is visualized by sequence conservation (gray shading, darker gray in
cases of overlap) for the genes (shown as arrows) located between the orthologs nadA (quinolinate synthase) and queE (7-carboxy-7-
deazaguanine synthase; not syntenic in Pseudomonas sp. Root9) (A) and between mtfA (zinc-dependent peptidase) and araC (AraC family
transcriptional regulator) (B). The pmnH gene and imnH gene are colored dark red and light red, respectively. Syntenic genes/gene fragments are
gray; nonsyntenic genes/gene fragments are white. Genes encoding a putative tripartite efﬂux pump are pink, and a tRNA-Lys gene is black. Genes
encoding a TPS system for a hemagglutinin repeat protein located upstream of pmnH-imnH are shown in yellow (A) and green (B), those encoding
the protein downstream of pmnH-imnH are in light blue, and fragmented hemagglutinin repeat genes are in dark blue. Gene triplets constituting
a putative pseudomonad class V CDI system (31) are in teal. Dotted lines indicate the lack of equivalent nucleotide sequence. In Pseudomonas
sp. 25R14, pmnH and imnH have been recruited to a different locus. Loci from P. ﬂuorescens strains LMG 5329 and SS101 (nadA-queE) and
Pseudomonas sp. strain FH4 (mtfA-araC) were added for comparison to similar regions lacking the pmnH-imnH gene couple. Pseudomonas species
abbreviations are the same as in Fig. 1.
FIG 3 (A) Spot assay of 5-fold serial dilutions of PmnH against susceptible strain P. ﬂuorescens LMG 1794 on CAA. (B) Spot assay of 5-fold serial dilutions of
PmnH against susceptible strain P. ﬂuorescens LMG 1794 on CAA supplemented with FeCl3 (50 M). (C) Spot assay against P. ﬂuorescens LMG 1794 with—from
left to right—PmnH, PmnH(H224A), PmnH(D227A), and PmnHΔColN. (D) Schematic representation of membrane-integrated bacteriocin immunity genes in
Pseudomonas. Color code is similar to that in Fig. 1A. Sec-dependent signal peptides, if present in the majority of the cases, are shown in a box. IM, inner
membrane. (E) Spot assay of PmnH against susceptible strain LMG 1794 equipped with imnH.
A Pseudomonas Dual Toxin Parasitizing FiuA ®
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strains were grown on CAA in the presence of FeCl3 (50 M), growth inhibition was
almost completely annihilated (Fig. 3B), suggesting that PmnH targets a protein that is
upregulated under iron-poor conditions.
To evaluate whether one or both toxin modules contribute to growth inhibition of
PmnH-susceptible strains, truncated forms without the ColN domain and forms with an
H224A or D227A mutation in the ColM domain were constructed and produced. The
former construct retains only the ColM domain, whereas the point mutants keep only
the functionality of the pore-forming domain, based on previous studies on abrogated
lipid II hydrolase activity of ColM domain mutants (12, 13, 28, 33). All indicator strains
remained susceptible to the point mutant variants [PmnH(H224A) and PmnH(D227A)]
(Fig. 3C), indicative of killing due to pore formation. No strain susceptible to the
pore-forming domain deletion (PmnHΔColN) could yet be identiﬁed.
PmnH immunity is conferred by a downstream-coupled gene. Based on previous
observations for modular pyocins and colicins, it was anticipated that (a) dedicated
immunity partner(s) would likely be encoded in close proximity to pmnH. No homo-
logue of cmi, the prototypical ColM immunity gene of E. coli (34), was found, but a
different gene encoding a protein product of 182 to 184 amino acids (aa) (~84%
pairwise identity among homologues), further designated ImnH, was conserved imme-
diately downstream of pmnH (on the same strand) (Fig. 1A). In line with its more
divergent toxin, the corresponding linked protein of Pseudomonas sp. 25R14 (182 aa)
also shows a lower degree of amino acid sequence identity (~60%). The ImnH proteins
lack a known protein domain and host four predicted TMHs, the ﬁrst of which may act
as a Sec-dependent signal sequence. PseuM immunity proteins (PmiAs) equally carry
four TMHs, the ﬁrst of which is equally predicted to act as a signal sequence, but these
proteins are considerably smaller (~137 aa) (16) and cannot meaningfully be aligned
with ImnHs. Notably, putative immunity partners of “mono” ColN-like pore formers
(ImmNs) in pseudomonads also bear four TMHs and have about the same size as ImnHs
(~187 aa) (Fig. 3D). These membrane proteins share borderline homology with ImnHs
(Fig. S4) and are encoded on the same strand as the bacteriocin genes, unlike the gene
organization of ColIa-type pore-forming bacteriocins (Fig. 1A). E. coli’s colicin N immu-
nity protein (Cni) (35, 36), although slightly smaller (174 aa), is equally constituted of 4
TMHs and shares ~20% amino acid identity with ImnH proteins.
The imnH gene of P. synxantha BG33R, cloned in shuttle vector pJB3Tc20, was
introduced in PmnH-susceptible strain LMG 1794 and conveyed full immunity in a spot
assay with PmnH (and with its H224A and D227A mutants) (Fig. 3E), indicative of
protection against ColN domain-mediated inhibition. Careful inspection of the context
of pmnH did not readily reveal a second candidate immunity partner, unlike putative
bacteriocins PsdH1 and PsdH2, which are accompanied by two putative immunity
modules downstream (3).
PmnH and PseuM bacteriocins target the ferrichrome transducer. A transposon
mutagenesis approach was pursued in order to identify the cell surface target of PmnH,
using indicator strain P. ﬂuorescens LMG 1794. Transconjugants were pooled, plated,
and exposed to spots of recombinant PmnH. Colonies growing inside halos were
selected. After conﬁrmation of the resistance phenotype, ﬂanking sequences of 11
mutants were determined. Of these, eight unique mutants carried the mobile element
inserted in the same gene, predicted to encode an OMP (Fig. 4A). The involvement of
the targeted OMP in conferring PmnH susceptibility was conﬁrmed via complementa-
tion with the wild-type gene from strain P. ﬂuorescens LMG 1794. Three different
transposon insertion mutants examined (CMPG2279, CMPG2281, and CMPG2283)
hereby regained their original bacteriocin susceptibility (Fig. 4B).
The motifs and domains present in the affected LMG 1794 gene product comprise
a Sec-dependent signal peptide, a “secretin and TonB N terminus short domain” (STN;
PF07660), a plug domain (PF07715), and a TonB-dependent receptor domain (PF00593)
(37, 38). The STN domain is required for interaction with regulatory proteins and
subsequent sigma factor activation, as part of cell surface signaling systems. As such,
Ghequire et al. ®
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this amino-terminal extension discriminates TonB-dependent transducers from TonB-
dependent receptors that lack an STN domain (39). The pseudomonad TonB-dependent
outer membrane proteins have been extensively studied, in particular in P. aeruginosa
(40–43), although the function of several of its predicted transporters remains elusive.
Comparison of the identiﬁed OMP to 13 TonB-dependent transporters with an STN
domain present in strain PAO1 revealed striking homology to FiuA (62.1% pairwise
amino acid identity). FiuA accounts for the uptake of the majority of iron-bound
ferrichrome by P. aeruginosa (44, 45). The next best sequence match among the PAO1
transporters was that to the ferrioxamine-responsive FoxA (only 34.7% amino acid
identity). The close similarity of the LMG 1794 OMP to FiuA is illustrated in the
phylogenetic tree constructed from alignment of the region comprising the STN and
plug domains that is well conserved among the transporters (Fig. 4C). The presence in
strain LMG 1794 of a syntenic tripartite module encoding homologues of the extracy-
toplasmic function (ECF) sigma factor (PA0472; 74% amino acid identity) and anti-sigma
factor (PA0471; 51% amino acid identity) functionally linked to PAO1 FiuA (PA0470)
further supports the assignment of the LMG 1794 target as a ferrichrome-binding OMP.
Interestingly, the ferrichrome receptor in E. coli (FhuA) was previously found to be the
outer membrane target of colicin M (46).
In light of (i) the structural similarities observed between the amino-terminal
domains of PseuMs and colicin M and (ii) the (low) homology between the amino-
terminal domains of PmnH and previously characterized PseuMs from P. aeruginosa
NCTC10332, P. ﬂuorescens Q8r1-96, and P. syringae pv. tomato DC3000 (Fig. S3), we
examined the possibility that FiuA may be parasitized by PseuM bacteriocins as well. To
this end, a ﬁuA transposon mutant of P. aeruginosa PAO1 (PA0470) (47) was tested for
altered susceptibility to the PseuM bacteriocin from P. aeruginosa NCTC10332. Previ-
ously, it was found that strain PAO1 displays a turbid-halo phenotype for this PseuM
bacteriocin (16). No such halo could be observed for this ﬁuA mutant, whereas a fecA
FIG 4 (A) Schematic representation of the targeted LMG 1794 gene with plasposon insertion sites generating mutants with absent PmnH-susceptible
phenotype. Complemented mutants are colored blue. (B) Spot assay of PmnH against LMG 1794 wild type (left), mutant CMPG2281 carrying empty control
vector pJB3Tc20 (middle), and CMPG2281 with pCMPG6268 (complementation, right). (C) ML phylogenetic tree of the STN and plug domains of TonB-
dependent transporters from Pseudomonas aeruginosa PAO1 and the PmnH-targeted OMP from P. ﬂuorescens LMG 1794 (colored blue). The scale bar represents
0.4 substitutions per site. Bootstrap values (percentages of 1,000 replicates) higher than 50 are shown at the branches. (D) Spot assay of PseuMNCTC10332 against
P. aeruginosa PAO1 wild type (left), fecA mutant (PA3901, middle), and ﬁuA mutant (PA0470, right). (E) Spot assay of PseuMQ8r1-96 against P. ﬂuorescens F113
wild type (left), F113 ﬁuA-deletion mutant CMPG2285 (middle), and CMPG2285 complemented with ﬁuAF113 (right).
A Pseudomonas Dual Toxin Parasitizing FiuA ®
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mutant, mutated in another TonB-dependent iron uptake transporter, still displays the
wild-type phenotype (Fig. 4D). Furthermore, a mutant with a deleted ﬁuA homologue
(PSF113_RS57875) was constructed for P. ﬂuorescens F113, a strain susceptible to the
PseuM bacteriocin from P. ﬂuorescens Q8r1-96 (16). This mutant proved insensitive to
PseuMQ8r1-96, and susceptibility was restored via complementation (Fig. 4E).
Taken together, these results provide evidence that ColM-like Pseudomonas bacte-
riocins indeed target FiuA, hereby supporting the hypothesis that the structural simi-
larity between PseuM and colicin M points to a shared functional ancestor (13). The
substantial sequence divergence among FiuA homologues from those strains of the
P. ﬂuorescens group that were included in our test panel (79.1% average pairwise amino
acid identity, 55.4% identical sites) may explain why not all P. ﬂuorescens strains are
susceptible. Notably, FiuA sequences of PmnH-susceptible P. ﬂuorescens strains tend to
cluster closely (Fig. S5).
DISCUSSION
By examining the functionality of a putative Pseudomonas bacteriocin with an
unprecedented dual ColM-ColN domain architecture, PmnH, we could attribute killing
activity to its ColN-type pore-forming module, identify the membrane protein ImnH as
a ColN immunity-providing partner, and show that for entry into susceptible cells the
ferrichrome transporter is parasitized, similarly to mono-ColM-domain bacteriocins of
pseudomonads.
In addition to the pyocin S5 bacteriotoxin domain of P. aeruginosa, phylogenetically
related to the enterobacterial colicin Ia, this study identiﬁes a second type of pore-
forming activity in pseudomonads, sharing apparent ancestry with the N-type colicin.
Whether the additional domain of PmnH, exhibiting striking similarity to ColM-type
bacteriocins from enterobacteria and pseudomonads, contributes to its functionality,
possibly broadening its target reach, could not be resolved since a strain susceptible to
a partially disabled PmnH, stripped of its pore-forming domain, could not yet be
identiﬁed. Somewhat arguing against enzymatic functionality of the ColM-like domain
are (i) the diverged sequences at the presumed active site for most strains (even more
degenerate in the PmnH sequence from Pseudomonas sp. 25R14), and (ii) the lack of
a second linked immunity gene. It should be pointed out that deviations from the
prototypical catalytic ColM motif do not necessarily preclude bacteriocin functionality
(30). In line with this, it was recently found that the pectobacterial ColM-type bacteri-
ocin pectocin M1 and a mutant form with a modiﬁed catalytic motif both provoke
cellular lysis when expressed in the periplasm of E. coli (48). By demonstrating that only
the pectocin M1 wild type retains lipid II degradation activity, this study indicates that
toxicity exerted by the ColM module may be more complex than merely enzymatic, as
initially thought. Consequently, a strictly conserved catalytic motif in PmnH’s ColM
module may not be essential to interfere with the peptidoglycan metabolism.
In view of the respective immunity pairs accompanying the predicted hybrid
nuclease bacteriocins PsdH1 and PsdH2 (3), the presence of a single immunity gene
linked to a dual-domain bacteriocin is rather unexpected. One cannot entirely exclude
that an immunity protein with relaxed protective capacity, linked to a bacteriocin of the
same type but encoded elsewhere in the genome, or encoded by a nonlinked immunity
gene, might prevent self-intoxication. The latter possibility has been proposed for the
ColM-type pectocin from Pectobacterium carotovorum PBR1692 and its putative cmi-like
immunity gene, separated by at least 84 kb (49). Alternatively, since divergence among
(putative) ColN-type immunity proteins in pseudomonads is considerable (only 30.5%
pairwise amino acid identity), one might speculate that membrane protein ImnH may
provide dual protection by expanded immunity capacity. This would be reminiscent of
PmiA membrane proteins that are promiscuous in providing protection against multi-
ple ColM-like PseuM bacteriocins (16). On the other hand, if PmnH’s ColM domain
interferes nonenzymatically with peptidoglycan metabolism, it is conceivable that a
single membrane-associated protein may concomitantly provide protection against
two bacteriocin activities that act on neighboring cell envelope constituents.
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The targeting of the FiuA ferrichrome transporter by PmnH and PseuM bacteriocins
is well in line with the previous observations on S-type pyocins aiming at TonB-
dependent OMPs that are involved in iron uptake and supports the hypothesis of
shared ancestry of ColM-type Pseudomonas bacteriocins and colicin M from E. coli.
Besides parasitism of determinants involved in the “ﬁght-for-iron” by modular bacte-
riocins from Pseudomonas (50), a similar strategy is adopted by a number of bacterio-
cins, such as colicins (e.g., ferric enterobactin receptor FepA by colicin B) (51), FhuA by
microcin J25 (52), FusA by pectocin M1 (53), and yersiniabactin receptor FyuA by
pesticin (54), underlining the pivotal role of iron for bacterial survival. At present, it is
not obvious which evolutionary scenario generated pmnH: a ColM-type bacteriocin
gene that recruited a colN/immN module or an N-type bacteriocin gene into which a
ColM-type bacteriocin gene became integrated.
Modular bacteriocins constitute an attractive novel drug lead in combating a
number of persistent infections caused by Gram-negative bacteria. Schulz et al. (55)
recently demonstrated that in planta-produced colicins can successfully clear E. coli-
spiked meat, and the potential of (several) pyocins in eradicating P. aeruginosa in a
murine lung model has equally been evidenced (56). A major pitfall, however, in the use
of bacteriocins, especially for the treatment of P. aeruginosa, is the presence of orphan
immunity genes. Therefore, preference should be given to the design of engineered
pyocins with frequently occurring targets coupled to toxin-immunity modules that are
less common in Pseudomonas genomes and for which orphan immunity genes are rare.
The picture of bacteriocin susceptibility is made more complex by the occurrence of
additional immunity genes downstream of certain bacteriocin-immunity gene pairs (3),
possibly serving as a reservoir to trap invading pyocins, and by immunity proteins
displaying a relaxed immunity phenotype. Instead of acquisition of an entire toxin-
immunity module with different functionalities to deal with opponents armored with
immunity against a particular bacteriocin, the recruitment of a second toxin module to
generate modular bacteriocins with dual toxin organization may therefore represent a
cunning bacterial strategy to circumvent bacteriocin resistance. In this context, the
combination of several toxin modules in one pyocin may also reduce the complexity of
bacteriocin cocktails and deserves further scrutiny as a tool to combat P. aeruginosa.
MATERIALS AND METHODS
Strains and growth conditions. Bacterial strains used in this study are listed in Table S2 in the
supplemental material. Pseudomonas strains were grown in Casamino Acids medium, King’s B medium,
or tryptic soy broth (TSB), and Escherichia coli was grown in 2.5% LB (media were from BD Bacto and MP
Biomedicals). E. coli and P. aeruginosa were grown at 37°C, and other Pseudomonas strains were grown
at 30°C with shaking at 200 rpm. Plasmids were propagated in E. coli TOP10F= (Invitrogen), and E. coli
Rosetta (DE3)pLysS (Novagen) was used for production of recombinant proteins. Growth media were
supplemented with ﬁlter-sterilized antibiotics when needed: ampicillin (100 g/ml; Sigma-Aldrich),
chloramphenicol (15 g/ml; Sigma-Aldrich), kanamycin (50 g/ml; Sigma-Aldrich), and tetracycline
(12.5 g/ml; Sigma-Aldrich). Media were solidiﬁed with bacteriological agar (1.5%; VWR). Bacterial strain
stocks were stored at 80°C in 25% (vol/vol) glycerol.
Plasmid construction. Genomic DNA was isolated with the Puregene Yeast/Bact. kit B (Qiagen).
Plasmids were harvested with the GenElute HP Plasmid Miniprep kit (Sigma-Aldrich). Competent E. coli
cells for heat shock transformation were prepared using standard methods (57), and electrocompetent
Pseudomonas cells were prepared with sucrose (VWR) (58). Restriction enzymes (New England BioLabs)
were used as speciﬁed by the supplier, and DNA fragments were ligated with T4 DNA ligase (Invitrogen).
Plasmid constructs were sequenced for validation by GATC Biotech (Constance, Germany). PCR ampli-
cons were generated with Q5 high-ﬁdelity DNA polymerase (New England BioLabs). Genomic DNA was
used as a template, and primers are listed in Table S3. Standard procedures were followed for DNA
electrophoresis. PCR fragments were puriﬁed with the GenElute PCR cleanup kit (Sigma-Aldrich), di-
gested, and ligated in pET28a, pJB3Tc20, or pAKE604. Point mutant constructs encoding truncated PmnH
forms were generated via splicing by overlap extension. Plasmids used in this study are summarized in
Table S2.
Overexpression and puriﬁcation of recombinant bacteriocins. Following heat shock transforma-
tion to E. coli Rosetta (DE3)pLysS, bacteria containing the plasmid of interest were grown in 500-ml
Erlenmeyer ﬂasks until the optical density at 600 nm (OD600) reached 0.7. Next, cultures were induced
with isopropyl--D-1-thiogalactopyranoside (Formedium) at a 1 mM ﬁnal concentration and incubated
for 16 h at 20°C with shaking at 200 rpm. Next day, cells were harvested (5,000  g, 20 min), and pellets
were frozen overnight. Subsequently, cells were thawed, resuspended in lysis buffer (300 mM NaCl
[VWR], 50 mM NaH2PO4 [VWR], 10 mM imidazole [Sigma-Aldrich], pH 8.0), and sonicated with a Branson
A Pseudomonas Dual Toxin Parasitizing FiuA ®
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Digital Soniﬁer 250 (18%, 10 cycles of 30 s on and 30 s off). Next, extracts were supplemented with
nuclease (0.01 U/l; Sigma-Aldrich), incubated at 37°C for 0.5 h, centrifuged (10,000  g, 30 min), and
ﬁltered (0.20 m pore size; Sarstedt). Soluble proteins were subsequently mounted on a 5-ml His-trap
column (GE Healthcare), and His-tagged proteins were eluted with a linear gradient of 10 to 500 mM
imidazole. The presence of recombinant protein was veriﬁed on Coomassie blue-stained SDS-PAGE gels.
Elution fractions were pooled, concentrated with Vivaspin ﬁlters (10,000 Da; Sartorius), and polished via
gel ﬁltration with a Superdex 200 column 16/60 (GE Healthcare), using Tris buffer (20 mM Tris [Sigma-
Aldrich], 200 mM NaCl, pH 7.5) as running buffer.
Bacteriocin assay. Activity of recombinant His-tagged protein was tested via spot assay. Ten-
microliter drops of protein were put on top of a lawn of bacteria. After drying, plates were incubated
overnight. On the following day, bacteriocin activity was detected as a halo appearing in the cell lawn.
Dialysis buffer was used as a control. The role of iron was tested via addition of FeCl3 (50 M;
Sigma-Aldrich) to CAA.
Plasposon mutagenesis and isolation of bacteriocin-resistant indicator mutants. A plasposon
mutant library of P. ﬂuorescens LMG 1794 was generated via biparental conjugation using E. coli BW20767
carrying transposon delivery vector pRL27 as a donor. Transconjugants were selected on tryptic soy agar
(TSA) supplemented with kanamycin and grown at 16°C for 72 h. Random insertion of the transposon
was veriﬁed by randomly selecting 10 LMG 1794 mutants following the plasposon rescue procedure and
sequencing the ﬂanking insertion positions (primers listed in Table S3). To isolate PmnH-resistant
mutants, all P. ﬂuorescens LMG 1794 plasposon mutants were pooled and 10-fold dilutions were plated
on TSA supplemented with kanamycin. Afterward, 50-l spots of puriﬁed PmnH at high concentrations
were added. On the following day, resistant clones could be retrieved as colonies growing inside halos.
After being streaked to single colonies, the resistance phenotype of the mutants was conﬁrmed, and the
insertion site was determined.
Construction of a P. ﬂuorescens F113 ﬁuA mutant. A deletion mutant in the ﬁuA homologue of
P. ﬂuorescens F113 (PSF113_RS57875) was constructed by ligating ~500-bp fragments upstream and
downstream of ﬁuA in suicide plasmid pAKE604. Sequence-veriﬁed plasmid was transformed to E. coli
S17-1 and transferred to P. ﬂuorescens F113 by biparental conjugation. F113 conjugants were streaked
to single colonies in the presence of kanamycin and individually grown in a test tube without antibiotic
for 12 h. Next, 10-fold serial dilutions were plated on TSA containing sucrose (8%; VWR) to select for the
loss of the cassette, and allelic exchange of the recombinants was validated by PCR using Taq polymerase
(New England BioLabs), using F113-speciﬁc primers (Table S3). As expected, in about half of the randomly
selected mutants ﬁuA was knocked out. The deletion construct resulted in a start-stop fusion with an
interspersed Gly-Ser (originating from the fragment-fusing BamHI site) pair and was validated via PCR
ampliﬁcation and subsequent sequencing. The construction of the F113 ﬁuA mutant was executed in
parallel to obtain four independent F113 mutant strains.
Phylogenetic and gene synteny analysis. Homology searches were performed via Blast searches,
using the NCBI nonredundant database. Sequence alignments and phylogenetic analyses were per-
formed with MUSCLE and PhyML, respectively, implemented in Geneious 7.1.7 (Biomatters Ltd., Auck-
land, New Zealand). Domain analyses were conducted with SMART (http://smart.embl-heidelberg.de)
and InterPro (https://www.ebi.ac.uk/interpro). The progressive MAUVE algorithm, implemented in Ge-
neious 7.1.7, was used to explore gene synteny (59).
Accession number. A draft genome sequence of P. ﬂuorescens DSM 50090 (LMG 1794) has been
released under a whole-genome sequencing (WGS) project of P. ﬂuorescens DSM 50090
(LHVP01000000) (60).
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/
mBio.01961-16.
FIG S1, TIF ﬁle, 2.6 MB.
FIG S2, TIF ﬁle, 2.4 MB.
FIG S3, TIF ﬁle, 0.3 MB.
FIG S4, TIF ﬁle, 1.1 MB.
FIG S5, TIF ﬁle, 0.2 MB.
TABLE S1, DOCX ﬁle, 0.01 MB.
TABLE S2, DOCX ﬁle, 0.02 MB.
TABLE S3, DOCX ﬁle, 0.02 MB.
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